Analyst Ratings for Beam Therapeutics Inc (BEAM)
BEAM Rating Summary
BEAM Price Target Summary
- Highest: $80.00 (H.C. Wainwright)
- Lowest: $8.00 (Benchmark)
- Average: $38.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$38.80 (+46.2%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
Avg. $ Target:
$38.80 (+46.2%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/20/2026 | Canaccord | N/A | New Coverage | Buy (N/A) |
74.00 (N/A) |
27.88 (26.54) |
-4.81% | Details |
| 1/7/2026 | UBS | Michael Yee | New Coverage | Neutral (N/A) |
28.00 (N/A) |
26.84 (26.54) |
-1.12% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
